Home / 2023 (Page 59)

Nearly 1 covid vaccine in every 7-8 people worldwide was administered using HMD’s syringeHMD had supplied 921.7 million syringes to the Government of India to facilitate over 2.2 billionVaccination in India till date.Hindustan Syringes & Medical Devices Ltd (HMD), one of the leading manufacturers

READ MORE

Georgia Embassy’s flagship education fair organized in Mumbai eyed inflated demand from Indian medical studentsThe second edition of the Georgia Education Fair organized in Mumbai focused on providing holistic information on medical and technology courses including MBBS, Dentistry, Data Science, Artificial Intelligence, and many among

READ MORE

The partnership will enable residents of Columbia Pacific Communities to avail Portea’s diverse home healthcare services at discounted rates. Portea will be the official Home Healthcare Partner of Columbia Pacific Communities for all its communities in India. Columbia Pacific Communities (CPC), India's largest and most

READ MORE

QOQ Q4 FY 23 vs. Q4 FY 22: The Financials  have been prepared in accordance with Ind AS (‘Indian Accounting Standards’):The Revenue from Operations is Rs. 3.40 Cr. in Q4 FY 23 as against Rs. 2.61 Cr. in Q4 FY 22,which is an increase of

READ MORE

AstraZeneca Pharma India Ltd. (AstraZeneca India), a leading biopharmaceutical company, announced the appointment of Bhavana Agrawal as Chief Finance Officer (CFO) with effect from October 1, 2023, following a transition period. She succeeds Rajesh Marwaha, who is retiring as CFO and full-time director of the

READ MORE

A team headed by Dr Deepak Gautam, Director of Orthopedic disciplines at Medicover Hospitals, Navi Mumbai successfully managed a 56-year-old patient by performing a total hip replacement using the latest minimally invasive procedure with a direct anterior hip approach for the first time in Navi

READ MORE

Concept Medical, a globally recognised leader in innovative medical devices, has achieved a remarkable milestone by becoming the first medical company to receive its fourth Investigational Device Exemption (IDE) approval from the United States Food and Drug Administration (USFDA) to treat Superficial Femoral Arteries (SFA).The

READ MORE